Blog articles for PHASE Scientific USA
Packed indoor events and fully booked flights where masks are few and far between suggest that the pandemic is a distant, unpleasant memory.
In reality, Covid-19 cases have steadily increased nationwide since the end of March. […]
April 04, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant of Omicron designated BA.2 (B.1.1529.2) was detected in the U.S. in January 2022, and the Centers […]
Despite its pervasiveness and spikes in Asia and Europe, the Covid-19 Omicron BA.2—dubbed the Stealth Omicron by the World Health Organization (WHO)—has appeared to have lost its choke-hold on the U.S. “It’s stealthy no more,“ Carl Zimmer remarks in his New York Times piece.
Omicron BA.2 […]
March 16, 2022 : The biotech conglomerate, PHASE Scientific USA, announced the FDA’s EUA green-light to launch INDICAID® Covid-19 Rapid Antigen Over-the-Counter (OTC)
tests nationwide. With INDICAID® OTC Delivered to leading retailers across the […]
Late last year, the American Medical Association (AMA) released an updated version of its document, ‘Special coding advice during COVID-19 public health emergency.’
This updated version, labeled v3.2, provides a broader list of coding scenarios, now 26 from the […]
February 4, 2022 : Set out below are Frequently Asked Questions (FAQs) regarding implementation of the Families First Coronavirus Response Act (FFCRA) and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). These FAQs have been prepared jointly by the […]
Starting February 1, 2022, Denmark has made the bold decision to lift most pandemic restrictions in the country. This includes mandatory isolation for infected individuals, vaccine passports for restaurants and concerts, […]
Effective January 26, the US government has formally withdrawn its vaccine and testing mandate for businesses after the Supreme Court ruled that the Occupational Safety and Health Administration (OSHA) had exceeded its authority.
The Supreme Court, in a 6-3 decision made on January 13, blocked […]
We all saw it coming. As soon as the Occupational Safety and Health Administration (OSHA) issued the Emergency Temporary Standard (ETS) on COVID-19 Vaccination and Testing, the pushback has caused an uproar in both private and public sectors.
Because of all the suits filed since the mandate, the […]
FULL COMPLIANCE WENT INTO EFFECT ON JANUARY 4, 2022
As of December 17, the U.S. Court of Appeals for the Sixth Circuit in Cincinnati overturned the Fifth Circuit’s ruling, blocking OSHA’s vaccine/testing mandate. This OSHA rule states that businesses of 100 or more employees must require vaccinations for their workers by January […]
